Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

Cited by (1,002)

Items 401–500 of 1,002

  1. PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy
    Jie Hua Xu, Lu Xie, Wei Guo · 2018 · Clinical Sarcoma Research
  2. Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival
    Honghua Zhang, Linwei Guo, Zheng Zhang, Yunlong Sun, Honglei Kang, Chao Song, Huiyong Liu, Zhuowei Lei, Jia Wang, Baoguo Mi et al. · 2019 · Journal of Cancer
  3. Age as prognostic factor in patients with osteosarcoma
    Melanie M. Hagleitner, Peter M. Hoogerbrugge, Winette T.A. van der Graaf, Uta E. Flucke, Hendrik W. B. Schreuder, Dunja Maroeska W.M. Te Loo · 2011 · Bone
  4. Giant cell rich osteosarcoma revisited—diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment
    Louis Tsun Cheung Chow · 2016 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  5. LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells
    Youguang Pu, Yiao Tan, Chunbao Zang, Fangfang Zhao, Cifeng Cai, Lingsuo Kong, Hui Deng, Fengmei Chao, Ran Xia, Minghua Xie et al. · 2021 · Cell Death and Disease
  6. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
    Bikesh Kumar Nirala, Taku Yamamichi, Jason Todd Yustein · 2023 · International Journal of Molecular Sciences
  7. Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping
    Jianqin Yan, Dengshuai Wei, Zijian Zhao, Kaichuang Sun, Yong Ye Sun · 2024 · Acta Biomaterialia
  8. Osteosarcoma of the mobile spine
    Katja Zils, Stefan Bielack, M. Wilhelm, Mathias Werner, R. Schwarz, Reinhard Windhager, Gerda Hofmann-Wackersreuther, T. Andus, Leo Kager, Titus Kühne et al. · 2013 · Annals of Oncology
  9. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Yong Shang, Liqing Wang, Quanyi Guo, Tu-Long Shi · 2015 · PubMed Central
  10. GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma
    Jie Luo, Yuan‐Zheng Xia, Jun Luo, Junhe Li, Chao Zhang, Hao Zhang, Ting Ma, Lei Yang, Ling‐Yi Kong · 2017 · Cancer Letters
  11. Comparative oncology: Integrating human and veterinary medicine
    Faheem Sultan, Bilal Ahmad Ganaie · 2018 · Open Veterinary Journal
  12. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma
    Hui Ye, Jinkuang Lin, Xuedong Yao, Yizhong Li, Xiaobin Lin, Hai Lü · 2018 · Cellular Physiology and Biochemistry
  13. lncRNA nuclear‐enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR‐186‐5p/HIF‐1α in osteosarcoma
    Hongyu Tan, Liang Zhao · 2018 · Journal of Cellular Biochemistry
  14. Licochalcone A Suppresses the Proliferation of Osteosarcoma Cells through Autophagy and ATM-Chk2 Activation
    Tai-Shan Shen, Yung-Ken Hsu, Yi‐Fu Huang, Hsuan‐Ying Chen, Cheng‐Pu Hsieh, Chiu-Liang Chen · 2019 · Molecules
  15. Sensitization of human osteosarcoma cells to Vγ9Vδ2 T‐cell‐mediated cytotoxicity by zoledronate
    Zhaoxu Li, Huiqin Peng, Qiang Xu, Zhaoming Ye · 2011 · Journal of Orthopaedic Research®
  16. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition
    Yanmao Wang, Huimin Wang, Runhua Zhou, Wanrun Zhong, Shengdi Lu, Zhongliang Ma, Yimin Chai · 2017 · Anti-Cancer Drugs
  17. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin
    Zhichang Zhang, Chun Yan Tang, Yang Dong, Jing Zhang, Ting Yuan, Xiaolin Li · 2017 · Journal of Cancer
  18. MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics
    Jyotika Varshney, Subbaya Subramanian · 2015 · Frontiers in Molecular Biosciences
  19. Percutaneous Computed Tomography-Guided Thermal Ablation of Pulmonary Osteosarcoma Metastases in Children
    Steven M. Yevich, Natalie Gaspar, Lambros Tselikas, Laurence Brugières, Hélène Pacquement, G. Schleiermacher, Marie‐Dominique Tabone, Ernesto Pearson, Sandra Canale, Jane C. Muret et al. · 2015 · Annals of Surgical Oncology
  20. Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways
    Yan A. Su, Daqian Wan, Wenqi Song · 2016 · Anti-Cancer Drugs
  21. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
    Joelle M. Fenger, Ryan David Roberts, Obiajulu Hans Iwenofu, Misty D. Bear, Xiaoli Zhang, Jason I. Couto, Jaime F. Modiano, William C. Kisseberth, Cheryl A. London · 2016 · BMC Cancer
  22. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution
    Wei Wang, Jing Yang, Yun Wang, Dianjun Wang, Gang Han, Jinpeng Jia, Meng Xu, Wenzhi Bi · 2016 · Pathology - Research and Practice
  23. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma
    Chao Yu, Bo Zhang, Yali Li, Xiaorui Yu · 2018 · Biomedicine & Pharmacotherapy
  24. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma
    Xin Huang, Wei Wu, Wenbo Yang, Xiangcheng Qing, Zengwu Shao · 2020 · Colloids and Surfaces B Biointerfaces
  25. Gene silencing of USP1 by lentivirus effectively inhibits proliferation and invasion of human osteosarcoma cells
    Jinbo Liu, Hongjun Zhu, Ning Zhong, Zi‐Feng Jiang, Lele Xu, Youping Deng, Zhenhuan Jiang, Hongwei Wang, Jinzhi Wang · 2016 · International Journal of Oncology
  26. Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways
    Pin-Yu Chang, Ming‐Ju Hsieh, Yih‐Shou Hsieh, Pei‐Ni Chen, Jia‐Sin Yang, Fang-Cheng Lo, Shun‐Fa Yang, Ko‐Hsiu Lu · 2016 · Environmental Toxicology
  27. Ninety Percent or Greater Tumor Necrosis Is Associated With Survival and Social Determinants of Health in Patients With Osteosarcoma in the National Cancer Database
    Spencer M. Richardson, L. Daniel Wurtz, Christopher D. Collier · 2022 · Clinical Orthopaedics and Related Research
  28. Multimodal Imaging of Osteosarcoma: From First Diagnosis to Radiomics
    Maurizio Cè, Michaela Iva Cellina, Thirapapha Ueanukul, Gianpaolo Carrafiello, Rawee Manatrakul, Phatthawit Tangkittithaworn, Suphaneewan Jaovisidha, Praman Fuangfa, DONALD RESNICK · 2025 · Cancers
  29. Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma
    Leonard Charles Marais, Julia Bertie, Reitze Nils Rodseth, Benn K. D. Sartorius, Nando Ferreira · 2015 · Journal of bone oncology
  30. Can Bone Tissue Engineering Contribute to Therapy Concepts after Resection of Musculoskeletal Sarcoma?
    Boris Michael Holzapfel, Mohit Prashant Chhaya, Ferry P.W. Melchels, Nina Pauline Holzapfel, Peter Michael Prodinger, Rüdiger von Eisenhart‐Rothe, Martijn van Griensven, Jan‐Thorsten Schantz, Maximilian Rudert, Dietmar Werner Hutmacher · 2013 · Sarcoma
  31. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells
    Yuehui Zhang, HAI-DONG LI, Bo Li, Sheng‐Dan Jiang, Lei‐Sheng Jiang · 2013 · Oncology Reports
  32. Conditional Survival Is Greater Than Overall Survival at Diagnosis in Patients With Osteosarcoma and Ewing’s Sarcoma
    Benjamin James Miller, Charles F. Lynch, Joseph A. Buckwalter · 2013 · Clinical Orthopaedics and Related Research
  33. MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1
    Yang Qu, Pan Su, Mingyang Kang, Rongpeng Dong, Jianwu Zhao · 2015 · Tumor Biology · Retracted
  34. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma
    Fanxiao Liu, Qingyu Zhang, Dezhi Zhu, Fengxia Liu, Zhenfeng Li, Jianmin Li, Bomin Wang, Dongsheng Zhou, Jinlei Dong · 2015 · Medicine
  35. The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence
    Andrea Angelini, Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Giulia Polverari, Giulia Trovarelli, Emanuela Palmerini, Stefano Maria Ferrari, Stefano Fanti, Pietro Ruggieri · 2017 · European Journal of Nuclear Medicine and Molecular Imaging
  36. Australian Adolescents and Young Adults: Trends in Cancer Incidence, Mortality, and Survival Over Three Decades
    David Murray Roder, Allison Warr, Pandora Patterson, Kimberley R. Allison · 2018 · Journal of Adolescent and Young Adult Oncology
  37. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR‐361‐5p and FoxM1
    Bin Shen, Ningfeng Zhou, Tao Hu, Weidong Zhao, Desheng Wu, Shanjin Wang · 2019 · Journal of Cellular Physiology
  38. Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-β axis
    Dan Zhang, Gang Cui, Chao Sun, Lei Li, Lei Lei, Ramone A. Williamson, Yanmeng Wang, Juan Zhang, Ping Chen, Aiying Wang et al. · 2019 · Biochemical and Biophysical Research Communications
  39. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial‐mesenchymal transition via Wnt/β‐catenin signaling pathway
    Qiuyue Ding, Fengbo Mo, Xianyi Cai, Wenda Zhang, Jinglong Wang, Shuhua Yang, Xianzhe Liu · 2020 · Journal of Cellular Biochemistry
  40. Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis
    Brandon J. Diessner, Brenda J. Weigel, Paari J Murugan, Lin Zhang, Jenny N. Poynter, Logan G. Spector · 2020 · JAMA Network Open
  41. The outstanding role of miR-132-3p in carcinogenesis of solid tumors
    Milad Rafat, Mahta Moraghebi, Masoomeh Afsa, Kianoosh Malekzadeh · 2021 · Human Cell
  42. Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma
    John D. Christie, Nicole Appel, Hannah Canter, Jazmin Galván Achi, Natalie M. Elliott, Ana Lemos de Matos, Lina S. Franco, Jacquelyn A. Kilbourne, Kenneth M. Lowe, Masmudur M. Rahman et al. · 2021 · Molecular Therapy — Oncolytics
  43. Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation
    Zhantao Deng, Xiaozhou Liu, Jiewen Jin, Haidong Xu, Qian Gao, Yong Wang, Jianning Zhao · 2016 · International Journal of Biological Sciences
  44. Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma
    Wang, Yifei, Tian, Xiangjun, Zhang, Wendong, Zhang, Zhongting, Lazcano, Rossana, Hingorani, Pooja, Roth, Michael E., Gill, Jonathan D., Harrison, Douglas J., Xu, Zhaohui et al. · 2022 · Molecular Cancer Therapeutics
  45. Epigenetic Changes Associated with Osteosarcoma: A Comprehensive Review
    Luke Twenhafel, DiAnna Moreno, Trista Punt, Madeline Kinney, Rebecca Jean Ryznar · 2023 · Cells
  46. Dog breeds and conformations predisposed to osteosarcoma in the UK: a VetCompass study
    Dan Gerard O'Neill, Grace L. Edmunds, Jade Urquhart-Gilmore, David B. Church, Lynda Rutherford, Matthew John Smalley, Dave C. Brodbelt · 2023 · Canine Medicine and Genetics
  47. Targeting transforming growth factor beta signaling in metastatic osteosarcoma
    Rongrong Ge, Gavin M. Huang · 2023 · Journal of bone oncology
  48. Osteosarcoma of the cranial vault and skull base in pediatric patients
    Caroline C. Hadley, Loyola V. Gressot, Akash J. Patel, Lisa L. Wang, Ricardo J. Flores, William E. Whitehead, Thomas G. Luerssen, Andrew H. Jea, Robert John Bollo · 2014 · Journal of Neurosurgery Pediatrics
  49. Down-Regulation of miR-3928 Promoted Osteosarcoma Growth
    Haidong Xu, Xiaozhou Liu, Jianning Zhao · 2014 · Cellular Physiology and Biochemistry
  50. RETRACTED: Lupeol Induces Apoptosis and Cell Cycle Arrest of Human Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway
    Yan Liu, Tingting Bi, Wei Dai, Gang Wang, Liqiang Qian, Genhai Shen, Quangen Gao · 2015 · Technology in Cancer Research & Treatment · Retracted
  51. Serum miR-542-3p as a prognostic biomarker in osteosarcoma
    Qicai Li, Shi-Rong Song, Guangzhen Ni, Li Yu, Xiaohui Wang · 2017 · Cancer Biomarkers
  52. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a
    Yanchen Chu, Yuan Fang, Jingwei Chi, Jing Li, Dongyang Zhang, Yun-wen Zou, Zhijie Wang · 2018 · Brazilian Journal of Medical and Biological Research
  53. Three‐Dimensional Osteosarcoma Models for Advancing Drug Discovery and Development
    Cátia F. Monteiro, Catarina A. Custódio, João Filipe Mano · 2018 · Advanced Therapeutics
  54. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma
    Naoki Mizoshiri, Toshiharu Shirai, Ryu Terauchi, Shinji Tsuchida, Yuki Mori, Daichi Hayashi, Tsunao Kishida, Yuji Arai, Osam Mazda, Tohru Nakanishi et al. · 2019 · Cellular Oncology
  55. Long non‑coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review)
    Hong Sun, Guoxuan Peng, Hongbin Wu, Miao Liu, Guping Mao, Xu Ning, Hua Yang, Jin Deng · 2020 · Biomedical Reports
  56. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF‐κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells
    Chenchen Li, Huan Gao, Xuemei Feng, Chuyao Bi, Jing Zhang, Jianyuan Yin · 2020 · Journal of Biochemical and Molecular Toxicology
  57. Role of intracellular water in the normal-to-cancer transition in human cells—insights from quasi-elastic neutron scattering
    Maria Paula M. Marques, Ana L. M. Batista de Carvalho, A. P. Mamede, Asha Dopplapudi, Victoria García Sakai, Luís A. E. Batista de Carvalho · 2020 · Structural Dynamics
  58. The FAP -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway
    Geni Ye, Maohua Huang, Yong Li, Jie Ouyang, Minfeng Chen, Qing Wen, Xiaobo Li, Hu-Hu Zeng, Pei Long, Zepei Fan et al. · 2021 · Acta Pharmaceutica Sinica B
  59. The role of m6A modification in pediatric cancer
    Yongping Chen, Lei Miao, Huiran Lin, Zhenjian Zhuo, Jing He · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  60. Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma
    Xiaozhou Liu, Yunlai Liu, Sujia Wu, Xin Shi, Lihong Li, Jianning Zhao, Haidong Xu · 2014 · Cell Biochemistry and Biophysics
  61. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways
    Feng Dong, Tingting Liu, Hao Jin, Wenbo Wang · 2017 · Canadian Journal of Physiology and Pharmacology
  62. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR‐199a‐3p
    Xüming Wang, Jilong Zou, Hongjun Chen, Peng Zhang, Zhiyuan Lu, Zhitao You, Jiabing Sun · 2019 · IUBMB Life
  63. LncRNA DDX11-AS1: a novel oncogene in human cancer
    Yubin Feng, Maomao Wu, Shuang Hu, Xiaoqing Peng, Feihu Chen · 2020 · Human Cell
  64. LncDC: a machine learning-based tool for long non-coding RNA detection from RNA-Seq data
    Minghua Li, Chun Liang · 2022 · Scientific Reports
  65. Natural medicine delivery from 3D printed bone substitutes
    Susmita Bose, Naboneeta Sarkar, Yongdeok Jo · 2023 · Journal of Controlled Release
  66. The expression and function of miRNA-451 in osteosarcoma
    Jiandong Yuan, Junzhe Lang, Cailong Liu, Kai Zhou, Lei Chen, Yangbo Liu · 2014 · Medical Oncology
  67. Modeling human osteosarcoma in the mouse: From bedside to bench
    Katherine A. Janeway, Carl R. Walkley · 2010 · Bone
  68. AHSA1 regulates proliferation, apoptosis, migration, and invasion of osteosarcoma
    Jianli Shao, Liang Wang, Cheng Frank Zhong, Renbin Qi, Yuming Li · 2015 · Biomedicine & Pharmacotherapy
  69. Malignant Osseous Tumors of the Pediatric Spine
    Han Jo Kim, Alexander S. McLawhorn, Matthew J. Goldstein, Patrick J. Boland · 2012 · Journal of the American Academy of Orthopaedic Surgeons
  70. Genome‐wide association study identifies the GLDC / IL33 locus associated with survival of osteosarcoma patients
    Roelof Koster, Orestis A. Panagiotou, William A. Wheeler, Eric Karlins, Julie M. Gastier, Sílvia Regina Caminada de Toledo, Antônio Sérgio Petrilli, Adrienne Margaret Flanagan, Roberto Tirabosco, Irene Louise Andrulis et al. · 2017 · International Journal of Cancer
  71. RETRACTED ARTICLE: Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis
    Jian Dai, Lijuan Xu, Guo-Dong Han, Haitao Jiang, Hailang Sun, Guotai Zhu, Xiaoming Tang · 2018 · Artificial Cells Nanomedicine and Biotechnology · Retracted
  72. Angiogenesis Process in Osteosarcoma: An Updated Perspective of Pathophysiology and Therapeutics
    Yusheng Li, Qing H. Liu, Jian Tian, Hongbo He, Wei Luo · 2018 · The American Journal of the Medical Sciences
  73. Bisphosphonates in the management of Paget's disease
    Stuart H. Ralston · 2020 · Bone
  74. Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 beta
    Xin Liang, Wei Guo, Tingting Ren, Yi Huang, Kunkun Sun, Hongliang Zhang, Yiyang Yu, Wei Wang, Jianfang Niu · 2020 · Cancer Letters
  75. Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: A Pediatric Surgical Oncology Research Collaborative Study
    Timothy B. Lautz, Zishaan Farooqui, Todd M. Jenkins, Todd E. Heaton, John J. Doski, Jo Cooke‐Barber, Andrew Jackson Murphy, Andrew M. Davidoff, Sara A. Mansfield, Eugene S. Kim et al. · 2020 · International Journal of Cancer
  76. A Spheroid Model of Early and Late‐Stage Osteosarcoma Mimicking the Divergent Relationship between Tumor Elimination and Bone Regeneration
    Fiona E. Freeman, Ross Burdis, Olwyn R. Mahon, Daniel John Kelly, Natalie Artzi · 2021 · Advanced Healthcare Materials
  77. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults
    Sabrina Jeane Prates Eleutério, Andreza Almeida Senerchia, Maria Teresa Almeida, Cecília Maria Lima da Costa, Daniel Lustosa, Luiz Mario Calheiros, José Henrique Barreto, Algemir Lunardi Brunetto, Carla Renata Pacheco Donato Macedo, Antônio Sérgio Petrilli · 2015 · Pediatric Blood & Cancer
  78. Chemotherapy compliance in patients with osteosarcoma
    Jyoti Bajpai, Ajay Puri, Kajal Shah, Deepa Susan, Nirmala Ajit Jambhekar, Bharat Rekhi, Saral R. Desai, Ashish Gulia, Sudeep Gupta · 2012 · Pediatric Blood & Cancer
  79. Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival
    Yao Wei Lu, GUO-FENG GUAN, Jie Chen, Bin Hu, Cong Sun, Qiong Ma, Yanhua Wen, Xiuchun Qiu, Yong Zhou · 2015 · Oncology Letters
  80. Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
    Xuelian Gong, Wei Li, Lin Dong, Fangfei Qu · 2020 · Journal of Molecular Histology
  81. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ
    Putao Yuan, Zhenhua Feng, Hai Huang, Gangliang Wang, Zhijun Chen, Guang Xu, Ziang Xie, Zhiwei Jie, Xiangde Zhao, Qingliang Ma et al. · 2022 · International Journal of Biological Sciences
  82. Switchable CAR T cell strategy against osteosarcoma
    Laura Hidalgo, Beatriz Somovilla-Crespo, Patricia Garcia-Rodriguez, Álvaro Morales‐Molina, Miguel Ángel Rodríguez-Milla, Javier Garcı́a-Castro · 2023 · Cancer Immunology Immunotherapy
  83. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma
    Qingbing Meng, Jie Zhao, Hongbing Liu, Guoyou Zhou, Wensheng Zhang, Xing-Li Xu, Minqian Zheng · 2014 · Tumor Biology
  84. MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16
    Bin Chen, Zhonglian Huang, Yuantao Zhang, Youbin Chen, Zhanchun Li · 2015 · Cellular Physiology and Biochemistry
  85. Krüppel‐like factor 4 promotes high‐mobility group box 1‐induced chemotherapy resistance in osteosarcoma cells
    Jun Xing Huang, Ke Liu, Deye Song, Muliang Ding, Junjie Wang, Qingping Jin, Jiangdong Ni · 2015 · Cancer Science
  86. Hypoxia-Inducible Factor-1 Expression Predicts Osteosarcoma Patients’ Survival: A Meta-Analysis
    Yurong Ouyang, Hui Li, Jie Bu, Xiaoyang Li, Zhuoyuan Chen, Tao Xiao · 2016 · The International Journal of Biological Markers
  87. Overexpression of miR-214 promotes the progression of human osteosarcoma by regulating the Wnt/β-catenin signaling pathway
    Xunbing Zhu, Zhong-Chuan Zhang, Guan-Sheng Han, Jun-Zhu Han, Dapeng Qiu · 2017 · Molecular Medicine Reports
  88. Pediatric head and neck bone sarcomas: An analysis of 204 cases
    Jacob S. Brady, Sei Yeon Chung, Emily J. Marchiano, Jean Anderson Eloy, Soly Baredes, Richard Chan Woo Park · 2017 · International Journal of Pediatric Otorhinolaryngology
  89. Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways
    Yanmao Wang, Daqian Wan, Runhua Zhou, Wanrun Zhong, Shengdi Lu, Yimin Chai · 2017 · Anti-Cancer Drugs
  90. A nomogram to predict prognosis in Ewing sarcoma of bone
    Qiang Zhou, Zongyi Wu, Zhong-Qin Lin · 2019 · Journal of bone oncology
  91. Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy
    Lei Zhao, Dongdong Bi, Xiaoyu Qi, Yifei Guo, Yue Feng, Xiangtao Wang, Meihua Han · 2019 · Nanotechnology
  92. FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway
    Dunxin Han, Mingming Wang, Zhongkai Yu, Long Yin, Changli Liu, Jianmin Wang, Yong-Jun Liu, Shengyang Jiang, Zhong-wu Ren, Jun Yin · 2019 · Cancer Management and Research
  93. Predictors of the Survival of Primary and Secondary Older Osteosarcoma Patients
    Zhan Wang, Bo Wu, Yuanxi Zhou, Xin Huang, Weibo Pan, Meng Liu, Xiaobo Yan, Nong Lin, Zhaoming Ye · 2019 · Journal of Cancer
  94. Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent population
    Chenan Zhang, Helen M. Hansen, Eleanor C. Semmes, Julio Gonzalez‐Maya, Libby M. Morimoto, Qingyi Wei, William C. Eward, Suzanne Bartholf DeWitt, Jillian H. Hurst, Catherine Metayer et al. · 2019 · Bone
  95. Polysaccharides from Dendrobium officinale inhibit proliferation of osteosarcoma cells and enhance cisplatin-induced apoptosis
    Xiaofeng Zhang, Shuna Duan, Shengchang Tao, Jiahui Huang, Chenxing Liu, Shangping Xing, Zhiyao Ren, Zhouxi Lei, Yunrong Li, Gang Wei · 2020 · Journal of Functional Foods
  96. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma
    Guijun Xu, Haixiao Wu, Yao Xu, Yan-ting Yann Zhang, Feng Lin, Vladimir P. Baklaushev, Vladimir Pavlovich Chekhonin, Karl Peltzer, Xin Wang, Min Mao et al. · 2020 · Orthopaedic Surgery
  97. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma
    Manuel Ruh, Marc P. Stemmler, Isabell Frisch, Kathrin Fuchs, Ruthger van Roey, Julia Kleemann, Maike Roas, Harald Schuhwerk, Rebecca L. Eccles, Abbas Agaimy et al. · 2021 · The Journal of Pathology
  98. Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment
    Yi Zhang, Tao Yuan, Zuxi Li, Chunyang Luo, Yuxuan Wu, Jiyong Zhang, Xiao Zhang, Weimin Fan · 2021 · ACS Biomaterials Science & Engineering
  99. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database
    Emel Rothzerg, Jiake Xu, David Wood, Sulev Kõks · 2021 · Experimental Biology and Medicine
  100. Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms
    Di Yu, Shilong Fu, Zhifei Cao, Meimei Bao, Gaochuan Zhang, Yanyan Pan, Wenming Liu, Quansheng Zhou · 2014 · Toxicology Letters